Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multinational, Multicenter Trial to Compare the Effects of Amlodipine/Benazepril to Benazepril and Hydrochlorothiazide Combined on the Reduction of Cardiovascular Morbidity and Mortality in Patients With High Risk Hypertension

NCT00170950 is registered in ClinicalTrials.gov with Novartis as lead sponsor.

NCT NCT00170950
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00170950 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multinational, Multicenter Trial to Compare the Effects of Amlodipine/Benazepril to Benazepril and Hydrochlorothiazide Combined on the Reduction of Cardiovascular Morbidity and Mortality in Patients With High Risk Hypertension
Lead sponsor
Novartis
Phase
Phase 3
Overall status
Terminated
Start date
October 31, 2003
Completion date
May 31, 2008
Enrollment
11,506 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension